Cardiovascular Markers
Apolipoprotein A-I (Apo A-I)
Apolipoprotein A-I Assay is intended for the in vitro quantitative determination of Apolipoprotein A-I (Apo A-I) in serum. It can be used as an aid for assessing the risk of coronary artery disease.
Apolipoprotein B (Apo B)
Apolipoprotein B Assay is intended for the quantitative in vitro determination of Apolipoprotein B (Apo B) in serum. It can be used as an aid for assessing the risk of coronary artery disease.
Cardiac Troponin I Assay
Cardiac Troponin I Assay is for the determination of cardiac troponin I in serum or plasma by latex enhanced immunoturbidimetric method.
HDL-Cholesterol Assay
HDL-Cholesterol reagent is intended for the in vitro quantitative determination of High Density Lipoprotein Cholesterol in human serum or plasma.
Heart-type Fatty Acid-Binding Protein (H-FABP) Assay
The Diazyme Heart-type Fatty Acid-Binding Protein (H-FABP) Assay is for the determination of heart-type fatty acid-binding protein concentration in serum or lithium-heparin plasma by latex-enhanced immunoturbidimetric method.
Homocysteine Enzymatic Assay ( Dual Vial Liquid Stable Format )
Homocysteine 2 Reagent Enzymatic Assay is intended for the in vitro quantitative determination of total L-homocysteine in serum or plasma.
Homocysteine Enzymatic Assay ( Three Vial Liquid Stable Format )
Homocysteine Enzymatic A ssay kit is intended for the in vitro quantitative determination of total L-homocysteine in serum or plasma.
hs-Troponin I Assay
Diazyme's hs-Troponin I (hs-cTnI) Assay is for the quantitative determination of cardiac troponin I in serum samples. The analyte should be measured according to specific application parameters for specific chemistry analyzers. Diazyme's hs-Troponin I assay kit consists of two liquid stable reagents and the calibrator and control are packaged separately.
LDL-Cholesterol Assay
The Diazyme LDL-Cholesterol Assay is intended for the in vitro quantitative determination of Low Density Lipoprotein Cholesterol in human serum or plasma.
Lipoprotein(a) [Lp(a)] Assay
Lp(a) is intended as a latex particle enhanced immunoturbidimetric assay for the in vitro quantitative determination of lipoprotein(a) [Lp(a)] concentration in human serum or plasma (EDTA) on clinical chemistry systems.
Lipoprotein-Associated Phospholipase A2 (Lp-PLA2)
The PLAC® Test for Lp-PLA2 Activity is an enzyme assay for the in vitro quantitative determination of Lp-PLA2 (lipoprotein-associated phospholipase A2) activity in EDTA plasma and serum on automated clinical chemistry analyzers. Lp-PLA2 activity is to be used in conjunction with clinical evaluation and patient risk assessment as an aid in predicting risk of coronary heart disease (CHD) in patients with no prior history of cardiovascular events
Myoglobin
Myoglobin Assay is for the quantitative determination of myoglobin in human serum and plasma.